Reproducibility of magnetic resonance perfusion imaging

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Zhang, Xiaomeng ^a,e   Pagel, Mark D ^a,b,c   Baker, Amanda F ^c,d   Gillies, Robert J ^e  

^a UNIVERSITY OF ARIZONA   (United States)

^b University of Arizona   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; GADOMELITOL; CONTRAST MEDIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VOLUME; BREAST TUMOR; CONTRAST TO NOISE RATIO; CORRELATION COEFFICIENT; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; DYNAMIC SUSCEPTIBILITY CONTRAST MAGNETIC RESONANCE IMAGING; FEMALE; HISTOGRAM; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PERFUSION; REPRODUCIBILITY; SIGNAL PROCESSING; SINGLE DRUG DOSE; ANIMAL; AREA UNDER THE CURVE; CHEMISTRY; MAGNETIC RESONANCE ANGIOGRAPHY; PATHOLOGY; PROCEDURES; STANDARDS; TUMOR CELL LINE;

ANIMALS; AREA UNDER CURVE; BREAST NEOPLASMS; CELL LINE, TUMOR; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MICE; REPRODUCIBILITY OF RESULTS;

EID: 84896140297     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089797     Document Type: Article

References (31)

1. Jennings D, Raghunand N, Gillies RJ (2008) Imaging hemodynamics. Cancer Metastasis Rev 27: 589-613.
2. Abdollahi A, Folkman J (2010) Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy. Drug Resist Updat 13: 16-28.
3. O'Connor JP, Jackson A, Parker GJ, Jayson GC (2007) DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 96: 189-195. (Pubitemid 46160619)
4. Smith JJ, Sorensen AG, Thrall JH (2003) Biomarkers in imaging: realizing radiology's future. Radiology 227: 633-638. (Pubitemid 36583016)
5. Yankeelov TE, Gore JC (2009) Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples. Curr Med Imaging Rev 3: 91-107. (Pubitemid 46773870)
6. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, et al. (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10: 223-232. (Pubitemid 29463104)
7. Jordan BF, Runquist M, Raghunand N, Baker A, Williams R, et al. (2005) Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478. Neoplasia 7: 475-485. (Pubitemid 40796142)
8. Marcus CD, Ladam-Marcus V, Cucu C, Bouche O, Lucas L, et al. (2009) Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives. Crit Rev Oncol Hematol 72: 217-238.
9. Myers AL, Williams RF, Ng CY, Hartwich JE, Davidoff AM (2010) Bevacizumab-induced tumor vessel remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation. J Pediatr Surg 45: 1080-1085.
10. Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307: 58-62.
11. Hormigo A, Gutin PH, Rafii S (2007) Tracking normalization of brain tumor vasculature bymagnetic imaging and proangiogenic biomarkers. Cancer Cell 11: 6-8. (Pubitemid 46054523)
12. Port M, Corot C, Rousseaux O, Raynal I, Devoldere L, et al. (2001) P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results. MAGMA 12: 121-127. (Pubitemid 32510130)
13. Port M, Corot C, Raynal I, Idee JM, Dencausse A, et al. (2001) Physicochemical and biological evaluation of P792, a rapid-clearance blood-pool agent for magnetic resonance imaging. Invest Radiol 36: 445-454. (Pubitemid 32803997)
14. Barrett T, Kobayashi H, Brechbiel M, Choyke PL (2006) Macromolecular MRI contrast agents for imaging tumor angiogenesis. Eur J Radiol 60: 353-366.
15. Galbraith SM, Lodge MA, Taylor NJ, Rustin GJ, Bentzen S, et al. (2002) Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis. NMR Biomed 15: 132-142. (Pubitemid 34213403)
16. Laking GR, West C, Buckley DL, Matthews J, Price PM (2006) Imaging vascular physiology to monitor cancer treatment. Crit Rev Oncol Hematol 58: 95-113.
17. Persigehl T, Wall A, Kellert J, Ring J, Remmele S, et al. (2010) Tumor blood volume determination by using susceptibility-corrected DeltaR2* multiecho MR. Radiology 255: 781-789.
18. Cha S (2003) Perfusion MR imaging: basic principles and clinical applications. Magn Reson Imaging Clin N Am 11: 403-413.
19. Haacke E, Brown R, Thompson M, Venkatesan R (1999) Magnetic resonance imaging: physical principles and sequence design: J. Wiley & Sons.
20. Patlak CS, Blasberg RG (1985) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5: 584-590. (Pubitemid 16218234)
21. Cutajar M, Mendichovszky IA, Tofts PS, Gordon I (2010) The importance of AIF ROI selection in DCE-MRI renography: reproducibility and variability of renal perfusion and filtration. Eur J Radiol 74: e154-160.
22. Daldrup H, Shames DM, Wendland M, Okuhata Y, Link TM, et al. (1998) Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. Pediatr Radiol 28: 67-78. (Pubitemid 28077437)
23. Abo-Ramadan U, Durukan A, Pitkonen M, Marinkovic I, Tatlisumak E, et al. (2009) Post-ischemic leakiness of the blood-brain barrier: a quantitative and systematic assessment by Patlak plots. Exp Neurol 219: 328-333.
24. Weir JP (2005) Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J Strength Cond Res 19: 231-240.
25. Ferrier MC, Sarin H, Fung SH, Schatlo B, Pluta RM, et al. (2007) Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model. Neoplasia 9: 546-555. (Pubitemid 47121828)
26. Watanabe H, Yamamoto S, Kunitoh H, Sekine I, Yamamoto N, et al. (2003) Tumor response to chemotherapy: the validity and reproducibility of RECIST guidelines in NSCLC patients. Cancer Sci 94: 1015-1020. (Pubitemid 37508986)
27. Pellis L, Franssen-van Hal NL, Burema J, Keijer J (2003) The intraclass correlation coefficient applied for evaluation of data correction, labeling methods, and rectal biopsy sampling in DNA microarray experiments. Physiol Genomics 16: 99-106. (Pubitemid 38420024)
28. Jackson A, Jayson GC, Li KL, Zhu XP, Checkley DR, et al. (2003) Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma. Br J Radiol 76: 153-162. (Pubitemid 36553239)
29. Allison DB (1993) Limitations of coefficient of variation as index of measurement reliability. Nutrition 9: 559-561.
30. Knapp WH, Debatin J, Layer K, Helus F, Altmann A, et al. (1985) Selective drug-induced reduction of blood flow in tumor transplants. Int J Radiat Oncol Biol Phys 11: 1357-1366. (Pubitemid 15067920)
31. Martinez GV, Zhang X, Garcia-Martin ML, Morse DL, Woods M, et al. (2011) Imaging the extracellular pH of tumors by MRI after injection of a single cocktail of T(1) and T(2) contrast agents. NMR Biomed.